These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3118784

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN, Holder IA.
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract] [Full Text] [Related]

  • 3. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
    Collins MS, Ladehoff D, Mehton NS.
    Antibiot Chemother (1971); 1991; 44():185-95. PubMed ID: 1801636
    [No Abstract] [Full Text] [Related]

  • 4. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS, Hector RF, Roby RE, Edwards AA, Ladehoff DK, Dorsey JH.
    Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
    [Abstract] [Full Text] [Related]

  • 5. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA.
    Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
    [No Abstract] [Full Text] [Related]

  • 6. [Adjuvant therapy with pseudomonas immunoglobulin in artificially ventilated patients at a surgical intensive care unit].
    Class I, Schorer R.
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):167-71. PubMed ID: 2504072
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections.
    Trafny EA, Grzybowski J, Patzer J, Popiel D, Wrembel-Wargocka J, Dzierzanowska D, Zawistowska-Marciniak I, Kobus K.
    Microbiol Immunol; 1991 Jun; 35(6):435-42. PubMed ID: 1921760
    [Abstract] [Full Text] [Related]

  • 10. Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.
    Grzybowski J, Trafny EA, Wrembel-Wargocka J, Patzer J, Dzierzanowska D, Zawistowska-Marciniak I, Kłos M.
    J Clin Microbiol; 1989 Jun; 27(6):1367-71. PubMed ID: 2502560
    [Abstract] [Full Text] [Related]

  • 11. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
    Cryz SJ, Fürer E, Germanier R.
    Infect Immun; 1983 Mar; 39(3):1072-9. PubMed ID: 6404817
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y, Carmeli Y, Gur E, Kuzmenko B, Gat A, Neville LF, Eren R, Dagan S, Navon-Venezia S.
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [Abstract] [Full Text] [Related]

  • 13. Anti-ETA IgG neutralizes the effects of Pseudomonas aeruginosa exotoxin A.
    Fogle MR, Griswold JA, Oliver JW, Hamood AN.
    J Surg Res; 2002 Jul; 106(1):86-98. PubMed ID: 12127813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
    Holder IA, Neely AN.
    J Burn Care Rehabil; 1989 Jul; 10(2):131-7. PubMed ID: 2496130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Broad-spectra human monoclonal antibodies that protect mice infected with Pseudomonas aeruginosa.
    Noguchi H, Yokota S, Ohtsuka H, Kohzuki T, Terashima M, Irie K.
    Antibiot Chemother (1971); 1991 Jul; 44():172-84. PubMed ID: 1724892
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.